Edition:
United States

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

18.95USD
15 Dec 2017
Change (% chg)

$0.14 (+0.74%)
Prev Close
$18.81
Open
$18.80
Day's High
$20.49
Day's Low
$18.37
Volume
468,421
Avg. Vol
--
52-wk High
$21.38
52-wk Low
$15.01

Chart for

About

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)

Overall

Beta: --
Market Cap(Mil.): $716.65
Shares Outstanding(Mil.): 37.82
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-OptiNose Inc Qtrly Net Loss ‍$4.23 Per Share​

* OPTINOSE INC - QTRLY NET LOSS ‍$4.23 PER SHARE​ Source text for Eikon: (http://bit.ly/2BiwpZA) Further company coverage:

Nov 27 2017

BRIEF-Optinose announces closing of initial public offering

* Optinose announces closing of initial public offering and full exercise of underwriters’ option to purchase additional shares of common stock Source text for Eikon: Further company coverage:

Oct 17 2017

Earnings vs. Estimates